0001093557-16-000727.txt : 20161020
0001093557-16-000727.hdr.sgml : 20161020
20161020195559
ACCESSION NUMBER: 0001093557-16-000727
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161019
FILED AS OF DATE: 20161020
DATE AS OF CHANGE: 20161020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEXCOM INC
CENTRAL INDEX KEY: 0001093557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330857544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582000200
MAIL ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Balo Andrew K
CENTRAL INDEX KEY: 0001323190
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51222
FILM NUMBER: 161945142
MAIL ADDRESS:
STREET 1: C/O DEXCOM, INC.
STREET 2: 5555 OBERLIN DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2016-10-19
0
0001093557
DEXCOM INC
DXCM
0001323190
Balo Andrew K
6340 SEQUENCE DRIVE
SAN DIEGO
CA
92121
0
1
0
0
EVP, Clinical and Regulatory
Common Stock
2016-10-19
4
S
0
4997.0
82.31
D
106345
D
On December 11, 2015, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan.
Included in this number are 70,084 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 23,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 8,334 of which were granted on March 8, 2014 and shall vest through March 8, 2017.
By: Kevin Sun For: Andrew K. Balo
2016-10-20